Skip to content

Nasdaq · CIK 0001616543

SENS Senseonics Holdings, Inc.

Insider trading from SEC Form 4. Last filing 8 d ago. Close $8.98 on Oct 9, 2026, +85% from the 52-week low and -13% from the high.

Senseonics Holdings, Inc. (SENS) has 74 SEC Form 4 filings on file from 11 insiders, the latest filed on Oct 5, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

10 open-market trades have been scored at SENS. The newest: Timothy T Goodnow (President and CEO) bought $100k of stock on Mar 13, 2026, filed Mar 16, 2026, scored 61 (notable). The largest of the 10 shown: Douglas A Roeder (director) bought $136k on Dec 12, 2024, scored 47 (moderate). 2 insiders bought within 14 days of each other around Mar 13, 2026.

SENS closed at $8.98 on Oct 9, 2026, 85% above its 52-week low and 13% below its 52-week high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company

Price and insider trades, last year

SENSOct 9, 2026 · close 8.98

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Senseonics Holdings, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
61NotableTimothy T Goodnow
President and CEO
buy
$100k
17,225 shares
+3%+7% from low-63% from high
54ModerateDouglas A Roeder
director
buy
$100k
17,500 shares
+17%+7% from low-63% from high
49ModerateEdelman Steven
director
buy
$66k
10,000 shares
+15%+25% from low-76% from high
58ModerateTimothy T Goodnow
President and CEO
buy
$101k
17,210 shares
+3%+18% from low-77% from high
50ModerateDouglas A Roeder
director
buy
$87k
15,000 shares
+18%+18% from low-77% from high
50ModerateFrederick T. Sullivan
Chief Financial Officer
buy
$32k
5,415 shares
+4%+18% from low-77% from high
44ModerateDouglas A Roeder
director
buy
$38k
75,000 shares
+5%-
47ModerateDouglas A Roeder
director
buy
$136k
325,000 shares
+30%-
46ModerateFrederick T. Sullivan
Chief Financial Officer
buy
$47k
124,933 shares
+5%-
50ModerateTimothy T Goodnow
President and CEO
buy
$98k
315,000 shares
+3%-

Transactions

The newest 50 of 92 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026Douglas A Roeder
director
AGrant or award
Common Stock
+1,480$9.96$15k172,6718 d ago
Oct 1, 2026Douglas S Prince
director
AGrant or award
Common Stock
+815$9.96$8,11770,1468 d ago
Oct 1, 2026Edelman Steven
director
AGrant or award
Common Stock
+1,292$9.96$13k92,3758 d ago
Oct 1, 2026Edward Fiorentino
director
AGrant or award
Common Stock
+1,418$9.96$14k87,3928 d ago
Jun 15, 2026Kenneth L Horton
GC & Corp. Development Advisor
FTax withholding
Common Stock
-9,545$7.18$69k285,512Jun 17, 2026
Jun 15, 2026Brian B Hansen
Chief Commercial Officer
FTax withholding
Common Stock
-5,420$7.18$39k126,937Jun 17, 2026
Jun 15, 2026Timothy T Goodnow
President and CEO
FTax withholding
Common Stock
-32,598$7.18$234k1,143,748Jun 17, 2026
May 19, 2026Kenneth L Horton
GC & Corp. Development Advisor
AGrant or award
Common Stock
+157,943$0.00$0295,057May 21, 2026
May 20, 2026Edward Fiorentino
director
AGrant or award
Common Stock
+9,852$0.00$083,339May 21, 2026
May 19, 2026Timothy T Goodnow
President and CEO
AGrant or award
Common Stock
+553,701$0.00$01,176,346May 21, 2026
May 20, 2026Stephen P DeFalco
director
AGrant or award
Common Stock
+9,852$0.00$0111,019May 21, 2026
May 19, 2026Brian B Hansen
Chief Commercial Officer
AGrant or award
Common Stock
+90,253$0.00$0132,357May 21, 2026
May 19, 2026Kenneth L Horton
GC & Corp. Development Advisor
AGrant or award
Employee Stock Option (right to buy)derivative
+217,338$0.00$0217,338May 21, 2026
May 20, 2026Stephen P DeFalco
director
AGrant or award
Stock Option (right to buy)derivative
+13,574$0.00$013,574May 21, 2026
May 20, 2026Edward Fiorentino
director
AGrant or award
Stock Option (right to buy)derivative
+13,574$0.00$013,574May 21, 2026
May 19, 2026Timothy T Goodnow
President and CEO
AGrant or award
Employee Stock Option (right to buy)derivative
+761,923$0.00$0761,923May 21, 2026
May 19, 2026Brian B Hansen
Chief Commercial Officer
AGrant or award
Employee Stock Option (right to buy)derivative
+124,193$0.00$0124,193May 21, 2026
May 15, 2026Timothy T Goodnow
President and CEO
FTax withholding
Common Stock
-28,598$5.82$166k622,645May 18, 2026
May 15, 2026Kenneth L Horton
GC & Corp. Development Advisor
FTax withholding
Common Stock
-7,320$5.82$43k137,114May 18, 2026
Apr 1, 2026Edward Fiorentino
director
AGrant or award
Common Stock
+2,124$6.65$14k73,487Apr 2, 2026
Mar 13, 2026Timothy T Goodnow
President and CEO
POpen-market purchase
Common Stock
+17,225$5.79$100k651,243Mar 16, 2026
Mar 13, 2026Douglas A Roeder
director
POpen-market purchase
Common Stock
+17,500$5.73$100k119,731Mar 16, 2026
Jan 2, 2026Edward Fiorentino
director
AGrant or award
Common Stock
+2,398$5.89$14k71,363Jan 5, 2026
Jan 2, 2026Douglas S Prince
director
AGrant or award
Common Stock
+1,379$5.89$8,12256,743Jan 5, 2026
Jan 2, 2026Douglas A Roeder
director
AGrant or award
Common Stock
+2,504$5.89$15k102,231Jan 5, 2026
Jan 2, 2026Edelman Steven
director
AGrant or award
Common Stock
+2,185$5.89$13k76,893Jan 5, 2026
Nov 15, 2025Timothy T Goodnow
President and CEO
FTax withholding
Common Stock
-27,067$6.26$169k634,018Nov 18, 2025
Nov 15, 2025Kenneth L Horton
GC & Corp. Development Advisor
FTax withholding
Common Stock
-5,997$6.26$38k144,434Nov 18, 2025
Nov 15, 2025Mukul JAIN
Chief Operating Officer
FTax withholding
Common Stock
-10,317$6.26$65k259,979Nov 18, 2025
Nov 15, 2025Francine Kaufman
Chief Medical Officer
FTax withholding
Common Stock
-4,605$6.26$29k123,948Nov 18, 2025
Nov 15, 2025Frederick T. Sullivan
Chief Financial Officer
FTax withholding
Common Stock
-6,402$6.26$40k150,626Nov 18, 2025
Nov 10, 2025Edelman Steven
director
POpen-market purchase
Common Stock
+10,000$6.55$66k74,708Nov 13, 2025
Nov 7, 2025Timothy T Goodnow
President and CEO
POpen-market purchase
Common Stock
-17,210$5.87$101k661,085Nov 10, 2025
Nov 7, 2025Douglas A Roeder
director
POpen-market purchase
Common Stock
+15,000$5.83$87k99,727Nov 10, 2025
Nov 7, 2025Frederick T. Sullivan
Chief Financial Officer
POpen-market purchase
Common Stock
+5,415$5.88$32k157,028Nov 10, 2025
Oct 1, 2025Edward Fiorentino
director
AGrant or award
Common Stock
+34,200$0.41$14k1,379,301Oct 3, 2025
Oct 1, 2025Douglas S Prince
director
AGrant or award
Common Stock
+19,673$0.41$8,1251,107,280Oct 3, 2025
Oct 1, 2025Douglas A Roeder
director
AGrant or award
Common Stock
+35,714$0.41$15k1,694,540Oct 3, 2025
Oct 1, 2025Edelman Steven
director
AGrant or award
Common Stock
+31,174$0.41$13k1,294,175Oct 3, 2025
Jul 1, 2025Edward Fiorentino
director
AGrant or award
Common Stock
+29,674$0.48$14k1,345,101Jul 3, 2025
Jul 1, 2025Douglas S Prince
director
AGrant or award
Common Stock
+17,069$0.48$8,1251,087,607Jul 3, 2025
Jul 1, 2025Douglas A Roeder
director
AGrant or award
Common Stock
+30,987$0.48$15k1,658,826Jul 3, 2025
Jul 1, 2025Edelman Steven
director
AGrant or award
Common Stock
+27,048$0.48$13k1,263,001Jul 3, 2025
Jun 16, 2025Timothy T Goodnow
President and CEO
FTax withholding
Common Stock
-79,646$0.51$41k12,877,501Jun 17, 2025
Jun 16, 2025Kenneth L Horton
GC & Corp. Development Advisor
FTax withholding
Common Stock
-35,784$0.51$18k3,008,622Jun 17, 2025
Jun 16, 2025Mukul JAIN
Chief Operating Officer
FTax withholding
Common Stock
-58,761$0.51$30k5,405,926Jun 17, 2025
Jun 16, 2025Francine Kaufman
Chief Medical Officer
FTax withholding
Common Stock
-28,853$0.51$15k2,571,057Jun 17, 2025
Jun 16, 2025Frederick T. Sullivan
Chief Financial Officer
FTax withholding
Common Stock
-27,263$0.51$14k3,032,251Jun 17, 2025
May 23, 2025Brian B Hansen
Chief Commercial Officer
AGrant or award
Common Stock
+842,084$0.00$0842,084May 29, 2025
May 23, 2025Brian B Hansen
Chief Commercial Officer
AGrant or award
Stock Option (right to buy)derivative
+1,187,987$0.00$01,187,987May 29, 2025
50 of 92 rows shown.

Insiders

Everyone who has filed a Form 4 here.

Questions about SENS

Answered from the filings on this page, as of the latest one.

Are insiders buying SENS?

No. In the last 90 days no insider at Senseonics Holdings, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade SENS on the open market?

Timothy T Goodnow (President and CEO) bought $100k of SENS on Mar 13, 2026 and filed the Form 4 on Mar 16, 2026. InsiderTell scored 61 (notable), with 2 insiders on the same side within 14 days.

How many insiders file Form 4 at Senseonics Holdings, Inc.?

11 people have filed a Form 4 at Senseonics Holdings, Inc., among them Stephen P DeFalco (director), Edward Fiorentino (director), Timothy T Goodnow (President and CEO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.